Diseases, Conditions, Syndromes

Progress towards protection from highly lethal Ebola, Marburg viruses

Ebola and Marburg filovirus disease outbreaks have typically occurred as isolated events, confined to central Africa. However, the recent Ebola epidemic spread to several African countries, and caused 11,000 deaths. That ...

Diseases, Conditions, Syndromes

High glycemic index/load diet linked to acne vulgaris

(HealthDay)—Patients with acne vulgaris have significantly higher glycemic index and glycemic load levels and significantly lower serum adiponectin levels, according to a study published in the July issue of the Journal ...

Diabetes

ADA: Empagliflozin linked to reduction in T2DM nephropathy

(HealthDay)—For patients with type 2 diabetes at high cardiovascular risk, empagliflozin is associated with a reduction in incident or worsening nephropathy, according to a study published online June 14 in the New England ...

Oncology & Cancer

Detecting an early biomarker for pancreatic cancer in blood

Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection ...

Neuroscience

Ever-changing moods may be toxic to the brain of bipolar patients

Bipolar disorder (BD) is a severe and complex mental illness with a strong genetic component that affects 2% of the world population. The disorder is characterized by episodes of mania and depression that may alternate throughout ...

Diseases, Conditions, Syndromes

Lower levels of vitamin D receptors in alopecia

(HealthDay)—Patients with alopecia areata (AA) and androgenetic alopecia (AGA) have significantly lower serum and tissue levels of vitamin D receptors (VDRs), according to a study published online May 6 in the Journal of ...

Diseases, Conditions, Syndromes

Markers that predict omalizumab response identified

(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published ...

page 23 from 40